Ladenburg Thalmann Financial Services’s Stemline Therapeutics, Inc. STML Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $2K | Hold |
180
| – | – | ﹤0.01% | 5146 |
|
|
2019
Q3 | $2K | Buy |
180
+100
| +125% | +$1.11K | ﹤0.01% | 5052 |
|
|
2019
Q2 | $1K | Hold |
80
| – | – | ﹤0.01% | 5223 |
|
|
2019
Q1 | $1K | Hold |
80
| – | – | ﹤0.01% | 5170 |
|
|
2018
Q4 | $1K | Hold |
80
| – | – | ﹤0.01% | 5157 |
|
|
2018
Q3 | $1K | Sell |
80
-394
| -83% | -$4.93K | ﹤0.01% | 5090 |
|
|
2018
Q2 | $7K | Hold |
474
| – | – | ﹤0.01% | 4471 |
|
|
2018
Q1 | $7K | Sell |
474
-9,800
| -95% | -$145K | ﹤0.01% | 4471 |
|
|
2017
Q4 | $160K | Sell |
10,274
-500
| -5% | -$7.79K | ﹤0.01% | 2381 |
|
|
2017
Q3 | $120K | Sell |
10,774
-1,920
| -15% | -$21.4K | ﹤0.01% | 2483 |
|
|
2017
Q2 | $117K | Hold |
12,694
| – | – | ﹤0.01% | 2420 |
|
|
2017
Q1 | $109K | Hold |
12,694
| – | – | ﹤0.01% | 2348 |
|
|
2016
Q4 | $136K | Buy |
12,694
+11,300
| +811% | +$121K | ﹤0.01% | 2090 |
|
|
2016
Q3 | $15K | Hold |
1,394
| – | – | ﹤0.01% | 3593 |
|
|
2016
Q2 | $9K | Hold |
1,394
| – | – | ﹤0.01% | 3857 |
|
|
2016
Q1 | $6K | Hold |
1,394
| – | – | ﹤0.01% | 4019 |
|
|
2015
Q4 | $9K | Hold |
1,394
| – | – | ﹤0.01% | 3758 |
|
|
2015
Q3 | $12K | Hold |
1,394
| – | – | ﹤0.01% | 3436 |
|
|
2015
Q2 | $16K | Buy |
1,394
+394
| +39% | +$4.52K | ﹤0.01% | 3398 |
|
|
2015
Q1 | $14K | Hold |
1,000
| – | – | ﹤0.01% | 3430 |
|
|
2014
Q4 | $17K | Hold |
1,000
| – | – | ﹤0.01% | 3110 |
|
|
2014
Q3 | $12K | Hold |
1,000
| – | – | ﹤0.01% | 3008 |
|
|
2014
Q2 | $15K | Buy |
+1,000
| New | +$15K | ﹤0.01% | 2866 |
|